Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda I Adler

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Seminars in Vascular Medicine|October 14, 2005
Treating high blood pressure in diabetes: the evidenceAmanda I Adler
BMJ (Clinical Research Ed.)|December 8, 2018
Incretins and cancer of the bile duct in type 2 diabetesAmanda I Adler
Diabetes Care|August 22, 2015
Trevor Orchard: Fruitful Contributions to Diabetes EpidemiologyAmanda I Adler
Diabetes Research and Clinical Practice|July 26, 2003
Managing diabetes: what to do about cardiovascular diseaseAmanda I Adler
The Lancet. Gastroenterology & Hepatology|December 3, 2019
NICE guidance on eluxadoline for treating irritable bowel syndrome with diarrhoeaAmanda I Adler
Nature Medicine|October 10, 2022
Endpoints and estimands: understanding trials of weight-loss drugsAmanda I Adler
Pharmacoeconomics|June 28, 2006
Simulating the real world of antihyperglycaemic therapies in type 2 diabetesAmanda I Adler
The Lancet. Diabetes & Endocrinology|November 21, 2016
Guilt, or guilt by association? Insulin therapy in type 2 diabetes and deathAmanda I Adler
Nature Medicine|April 16, 2021
The STEP 1 trial for weight loss: a step change in treating obesity?Amanda I Adler
The Lancet. Neurology|July 8, 2019
Ocrelizumab for primary progressive multiple sclerosisAmanda I Adler, Helen Knight
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Seminars in Vascular Medicine|October 14, 2005
Treating high blood pressure in diabetes: the evidenceAmanda I Adler
BMJ (Clinical Research Ed.)|December 8, 2018
Incretins and cancer of the bile duct in type 2 diabetesAmanda I Adler
Diabetes Care|August 22, 2015
Trevor Orchard: Fruitful Contributions to Diabetes EpidemiologyAmanda I Adler
Diabetes Research and Clinical Practice|July 26, 2003
Managing diabetes: what to do about cardiovascular diseaseAmanda I Adler
The Lancet. Gastroenterology & Hepatology|December 3, 2019
NICE guidance on eluxadoline for treating irritable bowel syndrome with diarrhoeaAmanda I Adler
Nature Medicine|October 10, 2022
Endpoints and estimands: understanding trials of weight-loss drugsAmanda I Adler
Pharmacoeconomics|June 28, 2006
Simulating the real world of antihyperglycaemic therapies in type 2 diabetesAmanda I Adler
The Lancet. Diabetes & Endocrinology|November 21, 2016
Guilt, or guilt by association? Insulin therapy in type 2 diabetes and deathAmanda I Adler
Nature Medicine|April 16, 2021
The STEP 1 trial for weight loss: a step change in treating obesity?Amanda I Adler
The Lancet. Neurology|July 8, 2019
Ocrelizumab for primary progressive multiple sclerosisAmanda I Adler, Helen Knight
Pageof 10